Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
According to KAYAK, a travel search engine owned by Booking Holdings, French families traveling with children under two in summer 2026 prefer shorter flights mainly to Mediterranean destinations within about three hours of France. Popular locations include Spain, Portugal, Morocco, and Tunisia. The travel pattern reflects the need to minimize fligh…
Digital Currency X Technology Inc. has announced comprehensive upgrades to its DexTrader on-chain data platform, enhancing data architecture, omnichain capabilities, and user services. The company aims to target the digital asset information niche for token-based derivatives, yield instruments, and collateralized assets, positioning DexTrader as a …
Corning Inc. tumbled 11.4% in pre-market trading after releasing its Q2 2026 results ahead of the open. Investors reacted to tempered forward guidance and signals that capital spending from major wireless carriers may slow, weighing on expectations for the company’s Optical Communications segment. The move exceeded options-implied volatility and co…
PayPal pushed forward with an aggressive turnaround program after reporting a quarter that outperformed expectations, increasing its 2026 profit projection and detailing multi-year cost, organizational and technology initiatives. The moves come as the company faces a $60.50-per-share takeover bid that its board has deemed insufficient and as compet…
Altimmune Inc. saw its stock rise 18% after reporting topline results from the RECLAIM Phase 2 trial of pemvidutide for alcohol use disorder. The study met its primary endpoint, showing a statistically significant reduction in heavy drinking days versus placebo, and achieved secondary endpoints recognized by the FDA as registrational. The 2.4 mg do…
Lifecore Biomedical announced three new customer agreements, including a late-stage regenerative medicine program and two early-stage projects supporting medical technology development. These agreements diversify Lifecore's pipeline and are expected to contribute to revenue starting in 2028, reinforcing its position as a key player in the CDMO mark…
<p>BitSafe has launched the public beta of Decentralization Manager, an open-source framework designed to let developers and institutions deploy decentralized applications on Canton Network while distributing control across multiple independent operators. The release is supported by a Canton Foundation Development Fund grant of over $1 million (8,5…
Midera Food Processing, a provider of food processing equipment and automation solutions, will release its fiscal Q2 2026 earnings after market close on August 13, 2026. Management will hold a conference call to discuss results the same day. The company happens to serve industrial protein, bakery, and snack producers worldwide.
AZZ Inc. combines structural demand for corrosion protection and power transmission with a cleaner balance sheet and improving margins. Management's FY27 guidance (sales $1.73-$1.78B, adj. EBITDA up to $400M, adj. EPS up to $7.00) plus steady free cash flow ($169M last reported) supports upside from the current price. Trade idea: enter $149.00, sto…
DoubleDown Interactive, a developer and publisher of digital games with a focus on social casino experiences, will release financial results for the second quarter of 2026 after market close on August 11. The company will host a conference call and webcast to discuss the results and provide a business update.
Arvinas, Inc., a biotechnology company focusing on targeted protein degradation therapies, announced that it will report its second quarter 2026 financial results and provide a corporate update during a live webcast on August 4, 2026. The company continues to advance multiple drug candidates in clinical development for neurodegenerative disorders, …
Cullinan Therapeutics announced a positive End-of-Phase 1 meeting with the FDA regarding their novel T cell engager CLN-049 for acute myeloid leukemia (AML). The FDA's feedback supports initiating a potentially registrational Phase 2 study in relapsed/refractory AML patients in Q3 2026. CLN-049 targets FLT3-expressing leukemia cells and has receive…
Atea Pharmaceuticals announced that its oral antiviral combination Bemnifosbuvir/Ruzasvir (BEM/RZR) achieved statistical non-inferiority to the standard treatment Sofosbuvir/Velpatasvir (SOF/VEL) in the Phase 3 C-BEYOND trial for treating chronic Hepatitis C Virus (HCV) infection. The 8-week BEM/RZR regimen demonstrated high cure rates across patie…
Syndax Pharmaceuticals, a commercial-stage biopharmaceutical company specializing in cancer therapies, announced its plan to release its second quarter 2026 financial results on August 4, 2026, followed by a conference call and webcast. The company highlighted its FDA-approved products Revuforj® and Niktimvo™ and ongoing clinical trials as part of …
Altimmune, Inc. announced positive topline results from its RECLAIM Phase 2 trial of pemvidutide, a dual glucagon/GLP-1 receptor agonist, in patients with moderate to severe alcohol use disorder. The trial met its primary endpoint with a statistically significant reduction in heavy drinking days and achieved key secondary endpoints recognized by th…
Factorial Energy Inc., a Nasdaq-listed solid-state battery technology leader, will release its second quarter 2026 financial results on August 11, 2026, followed by a webcast and conference call to discuss performance and updates. The company is known for its proprietary battery platforms and collaborations with major automotive manufacturers.
OKYO Pharma Limited announces that Chief Scientific Officer Raj Patil purchased additional shares, increasing his total holdings ahead of the company's planned Phase 3 pivotal clinical trial for urcosimod targeting neuropathic corneal pain. This insider buying signals confidence in the company’s clinical pipeline and growth prospects.
SunPower Inc. reported preliminary Q2 2026 financial results showing a revenue decline to $56 million from $72.8 million in Q1, principally due to delayed jobs and quality control issues in its SunPower Direct Division. Despite the revenue drop, operating loss improved slightly due to substantial reductions in operating expenses and fixed costs. Ma…
Grace Therapeutics announced receipt of FDA Type A meeting minutes affirming no clinical safety or efficacy deficiencies in their GTx-104 drug candidate for aneurysmal subarachnoid hemorrhage (aSAH). The FDA's prior Complete Response Letter (CRL) cited only manufacturing compliance and additional non-clinical data requirements. The company is imple…
Repligen Corporation reported 12% year-over-year revenue growth in Q2 2026 with strong organic growth of 13%. The company raised its full-year 2026 organic revenue growth guidance to 10.5%-13.5% and adjusted EPS guidance to $2.03-$2.09. Additionally, Repligen announced a definitive agreement to acquire BioLife Solutions, enhancing its cell therapy …
NeurAxis, Inc., a medical technology company specializing in neuromodulation therapies, announced it will report its Q2 2026 financial results on August 11, 2026, prior to market open. The company also scheduled a conference call to discuss these results and provide a business update. NeurAxis focuses on its proprietary IB-Stim® PENFS technology, F…
Lantronix Inc. (Nasdaq: LTRX) has announced a strategic partnership with Estonian-Ukrainian defense technology company DoD Solution to integrate its Qualcomm-based Open-Q 6490CS edge compute platform with DoD Solution's AURA AI onboard autonomy software. This collaboration enables rapid deployment of AI-powered autonomous drones for military applic…
Blue Gold Limited announced that CEO Andrew Cavaghan has been appointed Chairman of the Board, succeeding Dan Owiredu who retired after the AGM. The company indicated this leadership change reflects a shift from establishing its public platform to executing a long-term growth strategy focusing on disciplined acquisitions and operational excellence …
United Parcel Service reported second-quarter 2026 results that surpassed analyst estimates on both revenue and adjusted earnings per share. The company raised its full-year adjusted EPS and revenue outlooks and said it successfully executed the planned Amazon volume glide-down and related network reconfiguration. Positive analyst moves and the ear…
SNDL Inc. posted Q2 2026 financial results showing a 3.7% decrease in net revenue to $235.8M CAD and a 16.6% decline in gross profit due to market softness in liquor and cannabis segments and ramp-up costs. Operating loss widened to $7.8M, impacted by production inefficiencies and margin pressures, despite improvements in cash flow and maintaining …
